Discovery - University of Dundee - Online Publications

Library & Learning Centre


Asyms©-serat: A side-effect risk assessment tool to predict chemotherapy related toxicity in patients with cancer receiving chemotherapy

Research output: Chapter in Book/Report/Conference proceedingOther chapter contribution

View graph of relations


  • Julie Cowie
  • Kevin Swingler
  • Clare Leadbetter
  • Roma Maguire
  • Kathryn McCall
  • Nora Kearney

Research units


Original languageEnglish
Title of host publicationHEALTHINF 2008
Subtitle of host publicationProceedings of the First International Conference on Health Informatics
EditorsL Azevedo, AR Londral
Place of PublicationSetubal
PublisherInstitute for Systems and Technologies of Information, Control and Communication
Number of pages6
ISBN (Print)9789898111166
StatePublished - 2008
EventInternational Conference on Health Informatics - Funchal, Portugal


ConferenceInternational Conference on Health Informatics
Abbreviated titleHEALTHINF 2008
Internet address


Patients undergoing chemotherapy want specific information on potential toxicities of their treatment. Such information includes what side-effects they are likely to experience, how severe these side-effects will be, how long they will experience them for, and the best ways of managing them. As well as improving the experiences; of patients, information about potential side-effects may also be of significant benefit clinically,as patients who are 'at risk' of developing certain toxicities may be identified, facilitating more targeted,cost-effective interventions. This paper describes research that uses risk-modelling techniques for identifying patterns in patient side-effect data to aid in predicting side-effects patients are likely to experience. Through analysis of patient data, a patient can receive information specific to the symptoms they are likely to experience. A user-friendly software tool ASyMS©-SERAT (Advanced Symptom Management System-Side-Effect Risk Assessment Tool) has been developed, which presents side-effect information to the patients both at the start of treatment and reviews and monitors predictions with each new cycle of chemotherapy received.

Library & Learning Centre

Contact | Accessibility | Policy